Cidara Therapeutics Inc
NASDAQ:CDTX
Income Statement
Earnings Waterfall
Cidara Therapeutics Inc
Revenue
|
26.3m
USD
|
Operating Expenses
|
-71.6m
USD
|
Operating Income
|
-45.3m
USD
|
Other Expenses
|
-77.9m
USD
|
Net Income
|
-123.1m
USD
|
Income Statement
Cidara Therapeutics Inc
Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
19
N/A
|
21
+10%
|
23
+12%
|
27
+14%
|
10
-62%
|
12
+19%
|
12
-1%
|
41
+247%
|
46
+11%
|
50
+8%
|
54
+9%
|
28
-49%
|
61
+122%
|
64
+5%
|
83
+29%
|
85
+2%
|
57
-33%
|
64
+12%
|
46
-27%
|
39
-16%
|
26
-33%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(2)
|
(3)
|
0
|
0
|
|
Gross Profit |
(2)
N/A
|
(2)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
64
N/A
|
26
-59%
|
0
N/A
|
38
N/A
|
62
+62%
|
36
-43%
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(6)
|
(10)
|
(18)
|
(21)
|
(27)
|
(32)
|
(35)
|
(41)
|
(44)
|
(48)
|
(52)
|
(57)
|
(57)
|
(56)
|
(59)
|
(58)
|
(60)
|
(63)
|
(63)
|
(62)
|
(63)
|
(63)
|
(63)
|
(71)
|
(75)
|
(84)
|
(87)
|
(88)
|
(93)
|
(92)
|
(97)
|
(94)
|
(95)
|
(98)
|
(96)
|
(97)
|
(92)
|
(87)
|
(81)
|
(75)
|
(72)
|
|
Selling, General & Administrative |
(2)
|
(3)
|
(5)
|
(7)
|
(8)
|
(9)
|
(10)
|
(11)
|
(12)
|
(13)
|
(13)
|
(13)
|
(13)
|
(13)
|
(13)
|
(13)
|
(14)
|
(14)
|
(14)
|
(14)
|
(15)
|
(16)
|
(17)
|
(17)
|
(16)
|
(16)
|
(17)
|
(17)
|
(18)
|
(19)
|
(19)
|
(19)
|
(20)
|
(21)
|
(20)
|
(19)
|
(17)
|
(18)
|
(20)
|
(21)
|
(23)
|
|
Research & Development |
(3)
|
(7)
|
(11)
|
(15)
|
(19)
|
(23)
|
(26)
|
(30)
|
(32)
|
(36)
|
(39)
|
(43)
|
(44)
|
(43)
|
(46)
|
(44)
|
(46)
|
(49)
|
(49)
|
(48)
|
(48)
|
(46)
|
(47)
|
(54)
|
(58)
|
(68)
|
(71)
|
(71)
|
(75)
|
(73)
|
(77)
|
(75)
|
(74)
|
(77)
|
(76)
|
(78)
|
(75)
|
(69)
|
(61)
|
(51)
|
(46)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
|
Operating Income |
(7)
N/A
|
(12)
-60%
|
(18)
-53%
|
(21)
-19%
|
(27)
-28%
|
(32)
-20%
|
(35)
-10%
|
(41)
-15%
|
(44)
-8%
|
(48)
-10%
|
(52)
-7%
|
(57)
-9%
|
(57)
+0%
|
(56)
+2%
|
(59)
-6%
|
(58)
+2%
|
(60)
-4%
|
(63)
-5%
|
(63)
+1%
|
(62)
+1%
|
(44)
+29%
|
(42)
+6%
|
(40)
+4%
|
(44)
-10%
|
(64)
-47%
|
(72)
-12%
|
(76)
-5%
|
(47)
+38%
|
(47)
-1%
|
(42)
+10%
|
(42)
0%
|
(66)
-56%
|
(33)
+50%
|
(34)
-1%
|
(12)
+63%
|
(12)
+2%
|
(36)
-193%
|
(24)
+31%
|
(38)
-56%
|
(36)
+5%
|
(45)
-24%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(1)
|
0
|
4
|
4
|
6
|
5
|
1
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
1
|
2
|
2
|
2
|
3
|
5
|
|
Non-Reccuring Items |
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(85)
|
(85)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(8)
N/A
|
(12)
-56%
|
(18)
-51%
|
(21)
-18%
|
(27)
-28%
|
(32)
-19%
|
(35)
-9%
|
(41)
-15%
|
(44)
-8%
|
(48)
-10%
|
(52)
-7%
|
(57)
-9%
|
(57)
0%
|
(56)
+2%
|
(59)
-6%
|
(59)
+1%
|
(60)
-2%
|
(59)
+2%
|
(59)
+0%
|
(56)
+5%
|
(39)
+30%
|
(41)
-4%
|
(39)
+5%
|
(44)
-12%
|
(65)
-47%
|
(72)
-12%
|
(76)
-5%
|
(47)
+38%
|
(47)
-1%
|
(42)
+10%
|
(42)
+0%
|
(66)
-56%
|
(33)
+50%
|
(33)
0%
|
(12)
+64%
|
(11)
+8%
|
(34)
-206%
|
(22)
+34%
|
(36)
-60%
|
(118)
-228%
|
(126)
-6%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(1)
|
(0)
|
0
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(8)
|
(12)
|
(18)
|
(21)
|
(27)
|
(32)
|
(35)
|
(41)
|
(44)
|
(48)
|
(52)
|
(57)
|
(57)
|
(56)
|
(59)
|
(59)
|
(60)
|
(59)
|
(59)
|
(56)
|
(39)
|
(41)
|
(39)
|
(44)
|
(65)
|
(72)
|
(76)
|
(47)
|
(47)
|
(42)
|
(42)
|
(66)
|
(33)
|
(34)
|
(12)
|
(12)
|
(35)
|
(23)
|
(36)
|
(118)
|
(126)
|
|
Net Income (Common) |
(8)
N/A
|
(12)
-56%
|
(18)
-51%
|
(21)
-18%
|
(27)
-28%
|
(32)
-19%
|
(35)
-9%
|
(41)
-15%
|
(44)
-8%
|
(48)
-10%
|
(52)
-7%
|
(57)
-9%
|
(57)
0%
|
(56)
+2%
|
(59)
-6%
|
(69)
-17%
|
(70)
-2%
|
(69)
+2%
|
(69)
+0%
|
(56)
+20%
|
(39)
+29%
|
(41)
-4%
|
(42)
-2%
|
(47)
-12%
|
(67)
-43%
|
(75)
-11%
|
(74)
+1%
|
(47)
+37%
|
(47)
-1%
|
(42)
+10%
|
(44)
-4%
|
(63)
-43%
|
(33)
+47%
|
(34)
-1%
|
(13)
+62%
|
(15)
-18%
|
(35)
-132%
|
(23)
+35%
|
(36)
-59%
|
(115)
-216%
|
(123)
-7%
|
|
EPS (Diluted) |
-11.34
N/A
|
-17.63
-55%
|
-26.57
-51%
|
-31.05
-17%
|
-39.37
-27%
|
-46.72
-19%
|
-51.07
-9%
|
-58.48
-15%
|
-62.69
-7%
|
-66.52
-6%
|
-61.63
+7%
|
-67.29
-9%
|
-67.25
+0%
|
-63.69
+5%
|
-56.53
+11%
|
-58.53
-4%
|
-50.85
+13%
|
-55.16
-8%
|
-49.86
+10%
|
-36.35
+27%
|
-20.37
+44%
|
-28.25
-39%
|
-22.09
+22%
|
-22.96
-4%
|
-31.13
-36%
|
-36.03
-16%
|
-30.65
+15%
|
-15.79
+48%
|
-19.09
-21%
|
-16.19
+15%
|
-13.01
+20%
|
-17.55
-35%
|
-7.49
+57%
|
-9.61
-28%
|
-2.55
+73%
|
-3.38
-33%
|
-7.82
-131%
|
-5.25
+33%
|
-8.03
-53%
|
-25.26
-215%
|
-18.85
+25%
|